GlassScriptPhysician profile
Angelo J Cambio
NPI 1508879610
$8,848.93
in general payments reported to CMS, 2019-2025
45 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $847 · 2020: $312 · 2021: $685 · 2022: $2,252 · 2023: $2,807 · 2024: $1,287 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,634 · Consulting Fee: $2,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,633.71 |
| Consulting Fee | $2,120.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Medical Systems Corporation | $1,620.00 | 2023 | Oes Choledochofiberscope |
| Srs Medical Systems, INC. | $1,500.00 | 2022-2024 | Urocuff-Dc Disposable, Single, Urocuff, Ct3000 Pro Base Unit |
| Axonics, INC. | $963.79 | 2020-2023 | Bulkamid, Axonics |
| Astellas Pharma US INC | $867.48 | 2019-2024 | Xtandi, Myrbetriq, Veozah |
| Teleflex LLC | $674.66 | 2021-2024 | Urolift |
| Neotract INC. | $360.71 | 2019-2020 | |
| Abbvie INC. | $328.70 | 2019-2025 | Lupron Depot, Botox |
| Pfizer INC. | $215.87 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $201.93 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $192.98 | 2023-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $147.48 | 2025 | |
| 180 Medical, INC. | $143.43 | 2019-2024 | |
| Antares Pharma, INC. | $138.52 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Dendreon Pharmaceuticals LLC | $127.34 | 2019-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $114.87 | 2024-2025 | Adstiladrin, Fyremadel |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $113.04 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $101.69 | 2019-2024 | Aveed, Xiaflex |
| Coloplast Corp | $83.03 | 2019-2025 | |
| Urogen Pharma, INC. | $70.58 | 2022-2024 | |
| Medtronic, INC. | $66.92 | 2021-2023 | Interstim |
| Koelis INC. | $64.38 | 2024 | |
| Olympus America INC. | $54.66 | 2023-2024 | Double-J, Soltive, Olympus |
| Halozyme INC | $51.84 | 2023 | |
| Histosonics, INC. | $47.08 | 2025 | |
| Urovant Sciences INC | $46.43 | 2021 | |
| Allergan, INC. | $45.10 | 2019 | |
| Myovant Sciences INC. | $43.98 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $43.68 | 2020-2023 | |
| Dentsply Ih Ab | $40.46 | 2024 | Lofric |
| Ambu INC. | $35.56 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $30.48 | 2021 | |
| Blue Earth Diagnostics | $29.96 | 2025 | Posluma |
| Aytu Biopharma, INC. | $28.31 | 2019 | |
| Novo Nordisk INC | $26.68 | 2024 | |
| Profound Medical Corp. | $25.63 | 2025 | Tulsa-Pro |
| Endo USA, INC. | $23.57 | 2024 | Xiaflex, Aveed |
| Cycle Pharmaceuticals INC | $22.69 | 2025 | Venxxiva |
| Progenics Pharmaceuticals, INC. | $22.63 | 2023 | Pylarify |
| Accord Healthcare, INC. | $22.01 | 2023 | |
| Merck Sharp & Dohme LLC | $21.44 | 2024 | Keytruda |
| Agiliti Surgical, INC. | $20.18 | 2024 | Koelis Trinity Fusion Biopsy System, Sonablate Hifu, Endocare Cryocare Cs System |
| Palette Life Sciences, INC. | $19.20 | 2023 | |
| Edap Technomed INC | $18.00 | 2024 | |
| Boston Scientific Corporation | $17.46 | 2023 | Ams 700 Cxr Rte Kit |
| Valencia Technologies Corporation | $14.50 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Cambio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.